Pre-liver transplant biopsy in hepatocellular carcinoma: A potential criterion for exclusion from transplantation?

HPB

Volumn 15, Issue 6, 2013, Pages 418-427

  Young, Richard S ^a   Aldiwani, Mohammed ^a   Hakeem, Abdul R ^a   Nair, Amit ^a   Guthrie, Ashley ^a   Wyatt, Judy ^a   Treanor, Darren ^a   Morris Stiff, Gareth ^a   Jones, Rebecca L ^a   Prasad, K Rajendra ^a  

^a ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BENIGN TUMOR; CANCER PROGNOSIS; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PATIENT SELECTION; PREOPERATIVE EVALUATION; RADIODIAGNOSIS; TUMOR VOLUME; VIRUS HEPATITIS; ADVERSE EFFECTS; BIOPSY; CANCER GRADING; CARCINOMA, HEPATOCELLULAR; CELL DIFFERENTIATION; DECISION SUPPORT SYSTEM; ENGLAND; KAPLAN MEIER METHOD; LIVER NEOPLASMS; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; NEOPLASMS, MULTIPLE PRIMARY; PATHOLOGY; PREDICTIVE VALUE; PREOPERATIVE CARE; PROPORTIONAL HAZARDS MODEL; RADIOGRAPHY; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; TERTIARY CARE CENTER; TUMOR INVASION;

ADULT; AGED; BIOPSY; CARCINOMA, HEPATOCELLULAR; CELL DIFFERENTIATION; DECISION SUPPORT TECHNIQUES; ENGLAND; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM GRADING; NEOPLASM INVASIVENESS; NEOPLASMS, MULTIPLE PRIMARY; PATIENT SELECTION; PREDICTIVE VALUE OF TESTS; PREOPERATIVE CARE; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TERTIARY CARE CENTERS; TUMOR BURDEN;

EID: 84877707327     PISSN: 1365182X     EISSN: 14772574     Source Type: Journal    
DOI: 10.1111/hpb.12008     Document Type: Article

References (55)

1. Ferlay J, Bray F, Pisani P, Parkin DM,. (2004) GLOBOCAN 2002: Cancer Incidence, Mortality and Prevalence Worldwide IARC CancerBase No. 5. Version 2.0, Lyon: IARC Press.
2. Bosch FX, Ribes J, Cleries R, Diaz M,. (2005) Epidemiology of hepatocellular carcinoma. Clin Liver Dis 9: 191-211.
3. Molmenti EP, Klintmalm GB,. (2002) Liver transplantation in association with hepatocellular carcinoma: an update of the international tumour registry. Liver Transpl 8: 736-748. (Pubitemid 35012281)
4. De Carlis L, Giacomoni A, Pirotta V, Lauterio A, Slim AO, Sammartino C, et al. (2003) Surgical treatment of hepatocellular cancer in the era of hepatic transplantation. J Am Coll Surg 196: 887-897. (Pubitemid 36676550)
5. Bruix J, Llovet JM,. (2002) Prognostic prediction and treatment strategy in hepatocellular carcinoma. Hepatology 35: 519-524. (Pubitemid 34183954)
6. Bigourdan JM, Jaeck D, Meyer N, Meyer C, Oussoultzoglou E, Bachellier P, et al. (2003) Small hepatocellular carcinoma in Child A cirrhotic patients: hepatic resection versus transplantation. Liver Transpl 9: 513-520. (Pubitemid 36621722)
7. Clavien P-A, Lesurtel M, Bossuyt PMM, Gores GJ, Langer B, Perrier A,. (2012) Recommendations for liver transplantation for hepatocellular carcinoma: an international consensus conference report. Lancet Oncol 13: 11-22.
8. Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F, et al. (1996) Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 334: 693-699. (Pubitemid 26079803)
9. Jonas S, Bechstein WO, Steinmuller T,. (2001) Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis. Hepatology 33: 1080-1086. (Pubitemid 32378206)
10. Iwatsuki S, Starzl TE, Sheahan DG, Yokoyama I, Demetris AJ, Todo S, et al. (1991) Hepatic resection versus transplantation for hepatocellular carcinoma. Ann Surg 214: 221-229.
11. Goodman J, Schnitzler M, Lowell JA, Shenoy S, Jendrisak MD, Desai N, et al. (2005) Liver transplantation for hepatocellular carcinoma: expanding special priority to include stage III disease. Arch Surg 140: 459-464. (Pubitemid 40617362)
12. Llovet JM, Bru C, Bruix J,. (1999) Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis 19: 329-338.
13. Toso C, Mentha G, Majno P,. (2011) Liver transplantation for hepatocellular carcinoma: five steps to prevent recurrence. Am J Transplant 11: 2031-2035.
14. Samuel D, Colombo M, El-Serag H, Sobesky R, Heaton N,. (2011) Toward optimizing the indications for orthotopic liver transplantation in hepatocellular carcinoma. Liver Transpl 17 (Suppl. 2): 6-13.
15. Prasad KR, Young RS, Burra P, Zheng SS, Mazzaferro V, Moon DB, et al. (2011) Summary of candidate selection and expanded criteria for liver transplantation for hepatocellular carcinoma: a review and consensus statement. Liver Transpl 17 (Suppl. 2): 81-89.
16. Volk ML, Vijan S, Marrero JA,. (2008) A novel model measuring the harm of transplanting hepatocellular carcinoma exceeding Milan criteria. Am J Transplant 8: 839-846. (Pubitemid 351347750)
17. Freeman RB, Mithoefer A, Ruthazer R, Nguyen K, Schore A, Edwards EB,. (2006) Optimizing staging for hepatocellular cancer before liver transplantation: a retrospective analysis of the UNOS/OPTN database. Liver Transpl 12: 1504-1511. (Pubitemid 44594281)
18. Bruix J, Sherman M,. (2011) Management of hepatocellular carcinoma: an update. Hepatology 53: 1020-1022.
19. DuBay D, Sandroussi C, Sandhu L, Cleary S, Guba M, Cattral MS, et al. (2011) Liver transplantation for advanced hepatocellular carcinoma using poor tumour differentiation on biopsy as an exclusion criterion. Ann Surg 253: 166-172.
20. Cillo U, Vitale A, Bassanello M,. (2004) Liver transplantation for the treatment of moderately or well-differentiated hepatocellular carcinoma. Ann Surg 239: 150-159. (Pubitemid 38176347)
21. Ward J, Robinson PJ,. (2001) Combined use of MR contrast agents for evaluating liver disease. Magn Reson Imaging Clin N Am 9: 767-802.
22. Bruix J, Sherman M, Llovet JM, Beaugrand M, Lencioni R, Burroughs AK, EASL Panel of Experts on HCC. (2001) Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol 35: 4210-4230.
23. Bruix J, Sherman M,. Practice Guidelines Committee, American Association for the Study of Liver Diseases. (2005) Management of hepatocellular carcinoma. Hepatology 42: 1208-1236. (Pubitemid 43112690)
24. Bhartia B, Ward J, Guthrie JA, Robinson PJ,. (2003) Hepatocellular carcinoma in cirrhotic livers: double-contrast thin-section MR imaging with pathologic correlation of explanted tissue. AJR Am J Roentgenol 180: 577-584. (Pubitemid 36237194)
25. Neuberger J, Gimson A, Davies M, Akyol M, O'Grady J, Burroughs A, et al. (2008) Selection of patients for liver transplantation and allocation of donated livers in the UK. Gut 57: 252-257. (Pubitemid 351158055)
26. Pomfret EA, Washburn K, Wald C, Nalesnik MA, Douglas D, Russo M, et al. (2010) Report of a national conference on liver allocation in patients with hepatocellular carcinoma in the United States. Liver Transpl 16: 262-278.
27. Henderson J, Sherman M, Tavill A, Abecassis M, Chejfec G, Gramlich T,. (2003) AHPBA/AJCC consensus conference on staging of hepatocellular carcinoma: consensus statement. HPB 5: 243-250. (Pubitemid 38008080)
28. Esnaola NF, Lauwers GY, Mirza NQ, Nagorney DM, Doherty D, Ikai I, et al. (2002) Predictors of microvascular invasion in patients with hepatocellular carcinoma who are candidates for orthotopic liver transplantation. J Gastrointest Surg 6: 224-232. (Pubitemid 40433575)
29. Tamura S, Kato T, Berho M, Misiakos EP, O'Brien C, Reddy KR, et al. (2001) Impact of histological grade of hepatocellular carcinoma on the outcome of liver transplantation. Arch Surg 136: 25-30.
30. Klintmalm GB,. (1998) Liver transplantation for hepatocellular carcinoma: a registry report of the impact of the tumour characteristics on outcome. Ann Surg 228: 479-490. (Pubitemid 30194392)
31. Herrero JI, Sangro B, Quiroga J, Pardo F, Herraiz M, Cienfuegos JA, et al. (2001) Influence of tumour characteristics on the outcome of liver transplantation among patients with liver cirrhosis and hepatocellular carcinoma. Liver Transpl 7: 631-636. (Pubitemid 32677888)
32. Marsh JW, Dvorchik I, Bonham CA, Iwatsuki S,. (2000) Is the pathologic TNM staging system for patients with hepatoma predictive of outcome? Cancer 88: 538-543. (Pubitemid 30056926)
33. Schwartz ME, D'Amico F, Vitale A, Emre S, Cillo U,. (2008) Liver transplantation for hepatocellular carcinoma: are the Milan criteria still valid? Eur J Surg Oncol 34: 256-262. (Pubitemid 351312865)
34. Mullhaupt B, Durand F, Roskams T, Dutkowoski P, Heim M,. (2011) Is tumour biopsy necessary? Liver Transpl 17 (Suppl.): 14-25.
35. Deeks JJ, Altman DG,. (2004) Diagnostic tests 4: likelihood ratios. BMJ 329: 168-169.
36. Pawlick TM, Gleisner AL, Anders RA, Assumpcao L, Maley W, Choti MA,. (2007) Preoperative assessment of hepatocellular carcinoma tumour grade using needle biopsy implications for transplant eligibility. Ann Surg 245: 435-442. (Pubitemid 46673140)
37. Ng KK-C, Poon RT-P, Lo C-M, Liu C-L, Lam C-M, Ng IO-L, et al. (2004) Impact of preoperative fine-needle aspiration cytologic examination on clinical outcome in patients with hepatocellular carcinoma in a tertiary referral centre. Arch Surg 139: 193-200. (Pubitemid 38174716)
38. Berber E, Garland AM, Engle KL, Rogers SJ, Siperstein AE,. (2004) Laparoscopic ultrasonography and biopsy of hepatic tumours in 310 patients. Am J Surg 187: 213-218. (Pubitemid 38183435)
39. Silva MA, Hegab B, Hyde C, Huo B, Buckels JA, Mirza DF,. (2008) Needle track seeding following biopsy of liver lesions in the diagnosis of hepatocellular carcinoma: a systematic review and meta-analysis. Gut 57: 1592-1596.
40. Takamori R, Wong LL, Dang C, Wong L,. (2000) Needle-tract implantation from hepatocellular cancer: is needle biopsy of the liver always necessary? Liver Transpl 6: 67-72. (Pubitemid 30123370)
41. Kosugi C, Furuse J, Ishii H, Maru Y, Yoshino M, Kinoshita T, et al. (2004) Needle tract implantation of hepatocellular carcinoma and pancreatic carcinoma after ultrasound-guided percutaneous puncture: clinical and pathologic characteristics and the treatment of needle tract implantation. World J Surg 28: 29-32. (Pubitemid 38095788)
42. Chapoutot C, Perney P, Fabre D, Taourel P, Bruel JM, Larrey D, et al. (1999) Needle-tract seeding after ultrasound-guided puncture of hepatocellular carcinoma. A study of 150 patients. Gastroenterol Clin Biol 23: 552-556. (Pubitemid 29320956)
43. Kim SH, Lim HK, Lee WJ, Cho JM, Jang HJ,. (2000) Needle-tract implantation in hepatocellular carcinoma: frequency and CT findings after biopsy with a 19.5-gauge automated biopsy gun. Abdom Imaging 25: 246-250. (Pubitemid 30304979)
44. Huang GT, Sheu JC, Yang PM, Lee HS, Wang TH, Chen DS,. (1996) Ultrasound-guided cutting biopsy for the diagnosis of hepatocellular carcinoma-a study based on 420 patients. J Hepatol 25: 334-338.
45. Maturen KE, Nghiem HV, Marrero JA, Hussain HK, Higgins EG, Fox GA, et al. (2006) Lack of tumour seeding of hepatocellular carcinoma after percutaneous needle biopsy using coaxial cutting needle technique. AJR Am J Roentgenol 187: 1184-1187. (Pubitemid 44630819)
46. Durand F, Regimbeau J, Belghiti J, Sauvanet A, Vilgrain V, Terris B, et al. (2001) Assessment of the benefits and risks of percutaneous biopsy before surgical resection of hepatocellular carcinoma. J Hepatol 35: 254-258. (Pubitemid 32803481)
47. Caturelli E, Bartolucci F, Biasini E, Vigliotti ML, Andriulli A, Siena DA, et al. (2002) Diagnosis of liver nodules observed in chronic liver disease patients during ultrasound screening for early detection of hepatocellular carcinoma. Am J Gastroenterol 97: 397-405. (Pubitemid 34160767)
48. Vitale A, D'Amico F, Frigo AC, Grigoletto F, Brolese A, Zanus Z, et al. (2010) Response to therapy as a criterion for awarding priority to patients with hepatocellular carcinoma awaiting liver transplantation. Ann Surg Oncol 17: 2290-2302.
49. Wang P, Meng ZQ, Chen Z, Lin JH, Ping B, Wang LF, et al. (2008) Diagnostic value and complications of fine needle aspiration for primary liver cancer and its influence on the treatment outcome-A study based on 3011 patients in China. EJSO 34: 541-546. (Pubitemid 351514890)
50. Villanueva A, Hoshida Y, Toffanin S, Lachenmayer A, Alsinet C, Savic R,. (2010) New strategies in hepatocellular carcinoma: genomic prognostic markers. Clin Cancer Res 16: 4688-4694.
51. Trojan J, Schroeder O, Raedle J, Baum RP, Herrmann G, Jacobi V, et al. (1999) Fluorine-18 FDG positron emission tomography for imaging of hepatocellular carcinoma. Am J Gastroenterol 94: 3314-3319.
52. Ho CL, Yu SC, Yeung DW,. (2003) 11C-acetate PET imaging in hepatocellular carcinoma and other liver masses. J Nucl Med 44: 213-221.
53. Park J-W, Kim JH, Kim SK, Kang KW, Park KW, Choi J-I, et al. (2008) A prospective evaluation of 18F-FDG and 11C-acetate PET/CT for detection of primary and metastatic hepatocellular carcinoma. J Nucl Med 49: 1912-1921.
54. Numata K, Luo W, Morimoto M, Kondo M, Kunishi Y, Sasaki T, et al. (2010) Contrast-enhanced ultrasound of hepatocellular carcinoma. World J Radiol 2: 68-82.
55. Zarrinpar A, Kaldas F, Busuttil RW,. (2011) Liver transplantation for hepatocellular carcinoma: an update. Hepatobiliary Pancreat Dis Int 10: 234-242.